UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2008, Volume 52, Issue 10, pp. 818 - 827
heart failure | prognosis | anemia | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Failure, Diastolic - mortality | Heart Failure - complications | Anemia - mortality | Confidence Intervals | Prognosis | Risk Assessment | Heart Failure, Systolic - mortality | Humans | Middle Aged | Risk Factors | Heart Failure - physiopathology | Male | Anemia - physiopathology | Heart Failure, Diastolic - complications | Aged, 80 and over | Adult | Female | Aged | Odds Ratio | Chronic Disease | Anemia - etiology | Heart Failure - mortality | Heart Failure, Systolic - complications | Studies | Heart failure | Mens health | Anemia | Mortality | Regression analysis | Drug therapy | Multivariate analysis | Meta-analysis
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 13, pp. 1221 - 1230
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Death, Sudden, Cardiac - epidemiology | Heart Failure, Systolic - therapy | Humans | Middle Aged | Mortality | Male | Cardiac Pacing, Artificial | Stroke Volume | Defibrillators, Implantable | Cardiovascular Diseases - mortality | Electrocardiography | Female | Aged | Heart failure | Usage | Care and treatment | Defibrillators | Patient outcomes | Diagnosis | Patients | Health aspects | Transplants & implants | Coronary artery | Clinical trials | Death | Ventricle | Health risk assessment | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2006, Volume 47, Issue 10, pp. 1997 - 2004
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Failure - complications | Prognosis | Atrial Fibrillation - drug therapy | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Atrial Fibrillation - complications | Ventricular Dysfunction, Left - etiology | Male | Risk | Hospitalization | Heart Failure - drug therapy | Stroke Volume | Atrial Fibrillation - mortality | Cardiovascular Diseases - mortality | Female | Tetrazoles - therapeutic use | Aged | Chronic Disease | Benzimidazoles - therapeutic use | Heart Failure - mortality | Cardiac arrhythmia | Heart attacks | Drug therapy | Mortality | Clinical outcomes
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2011, Volume 364, Issue 1, pp. 11 - 21
SURVIVAL | TRIAL | LEFT-VENTRICULAR DYSFUNCTION | TASK-FORCE | SPIRONOLACTONE | ACUTE MYOCARDIAL-INFARCTION | ALDOSTERONE | CARDIAC FIBROSIS | ASSOCIATION | UMCG Approved | MINERALOCORTICOID RECEPTOR | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Hospitalization - statistics & numerical data | Mineralocorticoid Receptor Antagonists - adverse effects | Male | Combined Modality Therapy | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Cardiovascular Agents - therapeutic use | Heart Failure - classification | Defibrillators, Implantable | Cardiovascular Diseases - mortality | Female | Aged | Spironolactone - analogs & derivatives | Spironolactone - therapeutic use | Spironolactone - adverse effects | Heart Failure - mortality | Heart failure | Diagnosis | Drug therapy | Risk factors | Hospitalization | Heart attacks | Statistical analysis | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases/mortality | Cardiovascular Agents/therapeutic use | Aldosterone Antagonists/adverse effects/therapeutic use | Implantable | Kardiologi | Heart Failure/classification/drug therapy/mortality | Cardiac and Cardiovascular Systems | Spironolactone/adverse effects/analogs & derivatives/therapeutic use | Defibrillators | Hospitalization/statistics & numerical data
Journal Article
European journal of heart failure, ISSN 1388-9842, 05/2011, Volume 13, Issue 5, pp. 569 - 576
Heart failure | Mitral regurgitation | Catheter‐based therapy | Heart valves | Catheter-based therapy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Ventricular Dysfunction, Left - epidemiology | Comorbidity | Humans | Middle Aged | Kaplan-Meier Estimate | Prostheses and Implants | Male | Treatment Outcome | Mitral Valve Insufficiency - epidemiology | Mitral Valve Insufficiency - mortality | Mitral Valve Insufficiency - therapy | Feasibility Studies | Stroke Volume | Peptide Fragments - blood | Ultrasonography | Female | Aged | Mitral Valve Insufficiency - diagnostic imaging | Heart Failure - epidemiology | Mitral Valve Insufficiency - physiopathology | Natriuretic Peptide, Brain - blood | Heart Failure - mortality | Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2007, Volume 99, Issue 3, pp. 393 - 398
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Kidneys | Urinary system involvement in other diseases. Miscellaneous | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Kidney Failure, Chronic - physiopathology | Heart Failure - complications | Confidence Intervals | Glomerular Filtration Rate | Prognosis | Survival Rate - trends | Diastole | Follow-Up Studies | Humans | Middle Aged | Myocardial Contraction - physiology | Risk Factors | Proportional Hazards Models | Male | Systole | Disease Progression | Heart Failure - drug therapy | Cardiotonic Agents - therapeutic use | Kidney Failure, Chronic - complications | Digitalis Glycosides - therapeutic use | Female | Aged | Retrospective Studies | Heart Failure - mortality | Heart failure | Kidney diseases | Correlation analysis | Mortality | Chronic illnesses | Index Medicus | Abridged Index Medicus | and mortality | heart failure | chronic kidney disease | ejection fraction
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2009, Volume 54, Issue 5, pp. 410 - 418
heart failure | hypertension | contractility | pathophysiology | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Contraction | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - physiology | Male | Systole | Hypertension - physiopathology | Ventricular Dysfunction, Left - diagnostic imaging | Ventricular Dysfunction, Left - physiopathology | Echocardiography, Doppler | Aged, 80 and over | Hypertension - complications | Adult | Female | Aged | Heart Failure - diagnostic imaging | Heart Failure - etiology | Heart Failure - mortality | Studies | Cardiovascular disease | Blood pressure | Heart attacks | Drug therapy | Mortality
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2013, Volume 368, Issue 13, pp. 1210 - 1219
MORTALITY | CONTROLLED-TRIAL | CITY CARDIOMYOPATHY QUESTIONNAIRE | EPOETIN | MORBIDITY | REDUCTION | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Hematologic and hematopoietic diseases | Anemias. Hemoglobinopathies | General aspects | Diseases of red blood cells | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Shock, Septic - etiology | Double-Blind Method | Heart Failure, Systolic - drug therapy | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Heart Failure, Systolic - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Erythropoietin - adverse effects | Hematinics - adverse effects | Male | Thromboembolism - etiology | Erythropoietin - analogs & derivatives | Stroke - etiology | Anemia - drug therapy | Treatment Failure | Female | Aged | Darbepoetin alfa | Anemia - etiology | Hemoglobins - analysis | Heart Failure, Systolic - complications | Heart failure | Usage | Care and treatment | Anemia | Patient outcomes | Diagnosis | Clinical trials | Patient safety | Hemoglobin | Thromboembolism | Patients | Heart diseases | Cancer | Index Medicus | Abridged Index Medicus | Shock | Systolic/mortality | Hematinics/adverse effects | chronic heart failure | Erythropoietin/analogs & derivatives | Thromboembolism/etiology | Klinisk medicin | Heart Failure | Anemia/drug therapy | Hematinics/therapeutic use | Erythropoietin/therapeutic use | Hemoglobins/analysis | Anemia/etiology | Erythropoietin/adverse effects | Stroke/etiology | Clinical Medicine | Systolic/complications | Septic/etiology | Systolic/drug therapy
Journal Article
European journal of heart failure, ISSN 1388-9842, 2013, Volume 15, Issue 9, pp. 1062 - 1073
Angiotensin receptor neprilysin inhibitor | Renin–angiotensin | Neprilysin | LCZ696 | Chronic heart failure | Angiotensin receptor blocker | Neutral endopeptidase | ACE inhibitor | Natriuretic peptides | Renin-angiotensin | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Single-Blind Method | Prospective Studies | Heart Failure, Systolic - drug therapy | Heart Failure, Systolic - mortality | Humans | Survival Rate | Hospitalization | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Morbidity | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Neprilysin - antagonists & inhibitors | Peptide Fragments - blood | Tetrazoles - therapeutic use | Heart Failure, Systolic - blood | Angiotensin Receptor Antagonists - therapeutic use | Natriuretic Peptide, Brain - blood | Index Medicus | Study Design | Clinical Medicine | Klinisk medicin
Journal Article